Anthera Pharmaceuticals, Inc. (ANTH)
Develops experimental medicines for pancreatic and autoimmune diseases
$0.00+0.00%Healthcare
StockGlow Score
Bearish
BearishBullish
1 year ago+0.0%
The outlook
ANTH is trading near its 52-week low, well below both its 50- and 200-day moving averages. Analyst coverage appears minimal or absent. The overall sentiment reflected in available data leans heavily bearish.
What’s behind the score
Price trendBelow its 50- & 200-day averages
52-week range10% of the way from its 52-week low to high
Market cap
$2,617
52-wk high
$0.00
52-wk low
$0.00
50-day avg
$0.00
200-day avg
$0.00
Trailing P/E
—